Biomet recently reported the investigations into the company’s EBI unit, which makes electric stimulators to increase bone regeneration following spine surgery, to the Securities and Exchange Commission,
Recently, unsealed lawsuits in the states allege that Biomet promoted the off-label use of its spine stimulation devices, which resulted in fraudulent Medicare and Medicaid billing. Biomet denies the allegations.
Read the Wall Street Journal’s report on the Biomet spinal product investigations.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.